Jennifer Pretz

2.3k total citations · 1 hit paper
28 papers, 1.6k citations indexed

About

Jennifer Pretz is a scholar working on Molecular Biology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Jennifer Pretz has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Obstetrics and Gynecology and 8 papers in Reproductive Medicine. Recurrent topics in Jennifer Pretz's work include Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (8 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Jennifer Pretz is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Ovarian cancer diagnosis and treatment (8 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Jennifer Pretz collaborates with scholars based in United States, Canada and Paraguay. Jennifer Pretz's co-authors include Todd R. Golub, Benjamin L. Ebert, Azra Raza, Naomi Galili, Pablo Tamayo, Cindy Chang, David E. Root, Steven R. Ellis, Eyal C. Attar and Raymond H. Mak and has published in prestigious journals such as Nature, Blood and The Journal of Immunology.

In The Last Decade

Jennifer Pretz

24 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

2008 629 citations Benjamin L. Ebert, Jennifer Pretz et al. Nature profile →

Peers

Countries citing papers authored by Jennifer Pretz

Since Specialization

Citations

This map shows the geographic impact of Jennifer Pretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Pretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Pretz more than expected).

Fields of papers citing papers by Jennifer Pretz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Pretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Pretz. The network helps show where Jennifer Pretz may publish in the future.

Co-authorship network of co-authors of Jennifer Pretz

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Pretz. A scholar is included among the top collaborators of Jennifer Pretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Pretz. Jennifer Pretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical outcomes and dosimetric predictors of toxicity for re-irradiation of vaginal recurrence of endometrial cancer 2022 ·Brachytherapy ·Larissa J. Lee, (unknown), Teresa Cheng, Ivan Buzurović, Jennifer Pretz, Lisa Singer, Martin T. King	2
2	Definitive radiotherapy for vaginal recurrence of early-stage endometrial cancer: survival outcomes and effect of mismatch repair status 2021 ·International Journal of Gynecological Cancer ·(unknown), Teresa Cheng, (unknown), Ivan Buzurović, Jennifer Pretz, Lisa Singer, Martin T. King, Larissa J. Lee	5
3	A Phase 1 Dose-Escalation Trial of Radiation Therapy and Concurrent Cisplatin for Stage II and III Triple-Negative Breast Cancer 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Jennifer R. Bellon, Yu‐Hui Chen, (unknown), Alphonse G. Taghian, Julia S. Wong, Rinaa S. Punglia, (unknown), Laura Warren, Monica Krishnan, John G. Phillips, Jennifer Pretz, Rachel Jimenez, Stephanie G. MacAusland, Itai Pashtan, Chelsea Andrews, Steven J. Isakoff, Eric P. Winer, Sara M. Tolaney	7
4	Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes 2020 ·International Journal of Gynecological Cancer ·Alicia Smart, Daniela L. Buscariollo, (unknown), Ivan Buzurović, Teresa Cheng, Jennifer Pretz, (unknown), Martin T. King, Larissa J. Lee	4
5	Low-Dose Adjuvant Cylinder Brachytherapy for Endometrioid Endometrial Cancer 2019 ·Practical Radiation Oncology ·(unknown), Daniela L. Buscariollo, Teresa Cheng, Jennifer Pretz, (unknown), Ivan Buzurović, Lisa Singer, Martin T. King, Larissa J. Lee	4
6	Re-Irradiation for Vaginal Recurrence of Endometrial Cancer: Outcomes and Toxicity of Salvage Image-Guided Brachytherapy 2019 ·Brachytherapy ·(unknown), Teresa Cheng, Lisa Singer, (unknown), (unknown), Jennifer Pretz, Martin T. King, Larissa J. Lee	0
7	Low-Dose 3-Fraction Adjuvant Vaginal Brachytherapy for Early-Stage Endometrial Cancer 2019 ·Brachytherapy ·(unknown), Daniela L. Buscariollo, Teresa Cheng, (unknown), Lisa Singer, (unknown), Jennifer Pretz, Martin T. King, Larissa J. Lee	1
8	Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer 2017 ·Practical Radiation Oncology ·Jennifer Pretz, Michael A. Blake, Joseph H. Killoran, Harvey J. Mamon, Jennifer Y. Wo, Andrew X. Zhu, Theodore S. Hong	2
9	Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy 2017 ·The Oncologist ·Jennifer Pretz, Constance M. Barysauskas, Suzanne George, Jason L. Hornick, Chandrajit P. Raut, Yen-Lin E. Chen, Karen J. Marcus, Edwin Choy, Francis J. Hornicek, John E. Ready, Thomas F. DeLaney, Elizabeth H. Baldini	26
10	Dosimetric Consequences of Interobserver Variability in Delineating the Organs at Risk in Gynecologic Interstitial Brachytherapy 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Antonio L. Damato, (unknown), Michele Albert, Ryan J. Bair, Robert A. Cormack, Joanne Jang, Árṕad Kov́acs, Larissa J. Lee, Kimberley S. Mak, Kristina Mirabeau-Beale, Kent W. Mouw, John G. Phillips, Jennifer Pretz, Andrea Russo, John H. Lewis, Akila N. Viswanathan	20
11	Localized Adult Ewing Sarcoma (ES): Improved Outcomes With Ifosfamide and Etoposide (IE) Added to Cyclophosphamide, Doxorubicin, and Vincristine (CAV) Chemotherapy (CT) 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Jennifer Pretz, Constance M. Barysauskas, Chandrajit P. Raut, Jason L. Hornick, Jeffrey A. Morgan, James E. Butrynski, Karen J. Marcus, Phillip M. Devlin, John E. Ready, Marco Ferrone, Suzanne George, Elizabeth H. Baldini	1
12	Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis 2014 ·Blood ·Raajit K. Rampal, Fátima Al‐Shahrour, Omar Abdel‐Wahab, Jay Pravin Patel, (unknown), Craig H. Mermel, Adam J. Bass, Jennifer Pretz, Jihae Ahn, Todd Hricik, Outi Kilpivaara, Martha Wadleigh, Lambert Busque, D. Gary Gilliland, Todd R. Golub, Benjamin L. Ebert, Ross L. Levine	287
13	Chemoradiation Therapy 2013 ·Surgical Oncology Clinics of North America ·Jennifer Pretz, Jennifer Y. Wo, Harvey J. Mamon, Lisa A. Kachnic, Theodore S. Hong	14
14	Emergency Innovation: Implications for the Trauma Surgeon 2009 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Jennifer Pretz, David Magnus, David A. Spain	10
15	An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome 2008 ·PLoS Medicine ·Benjamin L. Ebert, Naomi Galili, Pablo Tamayo, (unknown), Raymond H. Mak, Jennifer Pretz, Shyam Tanguturi, Christine Ladd‐Acosta, Richard M. Stone, Todd R. Golub, Azra Raza	111
16	Identification of an Evolutionarily Conserved Transcriptional Signature of CD8 Memory Differentiation That Is Shared by T and B Cells 2008 ·The Journal of Immunology ·W. Nicholas Haining, Benjamin L. Ebert, (unknown), E. John Wherry, Quentin Eichbaum, John Evans, Raymond H. Mak, (unknown), Jennifer Pretz, Jill Angelosanto, John S. Smutko, Bruce D. Walker, Susan M. Kaech, Rafi Ahmed, Lee M. Nadler, Todd R. Golub	59
17	MicroRNA-Mediated Control of Cell Fate in Megakaryocyte-Erythrocyte Progenitors 2008 ·Developmental Cell ·Jun Lü, Shangqin Guo, Benjamin L. Ebert, Hao Zhang, Xiao Peng, (unknown), Jennifer Pretz, (unknown), (unknown), Raymond H. Mak, David Dombkowski, Frederic I. Preffer, David T. Scadden, Todd R. Golub	263
18	Identification of RPS14 as a 5q- syndrome gene by RNA interference screen breakdown → 2008 ·Nature ·Benjamin L. Ebert, Jennifer Pretz, (unknown), Cindy Chang, Pablo Tamayo, Naomi Galili, Azra Raza, David E. Root, Eyal C. Attar, Steven R. Ellis, Todd R. Golub	629
19	High Throughput Screen To Identify Small Molecules That Differentially Regulate Expression of the Globin Genes. 2005 ·Blood ·Benjamin L. Ebert, Raymond H. Mak, Jennifer Pretz, D. D. Peck, Stephen E. Haggerty, Nicola Tolliday, Todd R. Golub	0
20	An RNA Interference Model of RPS19 Deficiency in Diamond Blackfan Anemia Recapitulates Defective Erythropoiesis and Rescue by Dexamethasone: Identification of Dexamethasone Responsive Genes by Microarray. 2004 ·Blood ·Benjamin L. Ebert, Michele Lee, Jennifer Pretz, Todd R. Golub, Colin A. Sieff	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact